News
Dr. Alicia Arnold and Dr. Priyanka Raval discuss first- and later-line treatment options for those with ER-positive, ...
I have been on an aromatase inhibitor for the past eight months and have side effects that keep me from having a good quality of life. I am supposed to be on it for five years, but I do not want ...
A number of adjuvant breast cancer trials are currently evaluating all 3 third-generation aromatase inhibitors relative to the current standard, tamoxifen for 5 years. In comparing efficacy and ...
Hosted on MSN1mon
A Better Option For Women With Common Type Of Advanced Breast Cancer: The SERENA-6 Trial Provides Hope - MSNToday’s standard first-line care combines an aromatase inhibitor with one of three CDK4/6 inhibitors (palbociclib, ribociclib, or abemaciclib). These drugs slow cancer growth by putting the cell ...
Panelists discuss the SERENA-6 trial evaluating camizestrant, which uniquely enrolled patients with molecularly detected ESR1 ...
I have been on an aromatase inhibitor for the past eight months and have side effects that keep me from having a good quality of life. I am supposed to be on it for five years, but I do not want ...
How many, if any, cases of nervous system disorders have been reported because of A-C breast cancer chemotherapy? I'm 45 and had treatment at 39 and 40. I now experience a very exaggerated amount of ...
Aromatase inhibitors work to lower your levels of estrogen. These oral meds are usually taken once a day. They include the drugs letrozole (Femara), anastrozole (Arimidex), and exemestane (Aromasin).
ReproNovo Announces First Participant Included in U.S. Phase 2 Trial of RPN-001 for Male Infertility
RPN-001 is a novel orally administered aromatase inhibitor being developed for the treatment of infertility in men with low ...
TUESDAY, Sept. 17, 2024 (HealthDay News) -- For postoperative patients with breast cancer, the duration of aromatase inhibitor (AI) treatment is not associated with the risk for coronary artery ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results